Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
02 Jul, 2026, 03.15 PM IST
Why did market rise today? Sensex gains 444 points, Nifty closes above 24,000. 3 key factorsIndian stock markets surged on Wednesday, breaking a two-day losing spell. Positive global sentiment and other factors propelled investor c...
01 Jul, 2026, 04.01 PM IST
Lower crude, easing FII selling brighten market outlook; large-cap financials offer better value: Kunal VoraIndian equities are poised for a brighter outlook as crude oil prices retreat, corporate earnings show resilience, and foreign investor sel...
01 Jul, 2026, 02.26 PM IST
Sensex rises over 150 points, Nifty above 23,900 as investors weigh Iran tensions, weak monsoon concernsIndian stock markets opened the second half of 2026 with modest gains after recent declines. Investors are closely watching escalating US-I...
01 Jul, 2026, 09.36 AM IST
India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
30 Jun, 2026, 07.14 PM IST
Hyderabad is India's most expensive GCC office market, commands 15% premiumHyderabad has emerged as India's priciest office market for Global Capability Centres (GCCs), commanding a 15% premium. The city leads the ...
30 Jun, 2026, 07.13 PM IST
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
30 Jun, 2026, 02.54 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
29 Jun, 2026, 04.05 PM IST
India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
28 Jun, 2026, 06.00 PM IST
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
28 Jun, 2026, 05.46 AM IST
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
27 Jun, 2026, 11.45 AM IST
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
26 Jun, 2026, 11.31 AM IST
IndiaMART doubles down on AI to curb fake listings, improve buyer interactionIn a bold move, IndiaMART is ramping up its AI-related budget, with plans to double its expenditure biannually. This funding will be direct...
25 Jun, 2026, 02.58 PM IST
Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
24 Jun, 2026, 01.17 AM IST
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
24 Jun, 2026, 01.03 AM IST
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
23 Jun, 2026, 04.33 PM IST
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
23 Jun, 2026, 12.05 PM IST